Molecular tinkering doubles cancer drug's efficacy

(Duke University) Researchers at Duke University have molecularly repackaged a widely used cancer drug called paclitaxel, more than doubling its effectiveness at destroying tumors than the current gold-standard pharmaceutical, Abraxane.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news